Work

Correction: Intravitreal injection of fibrillin 2 (Fbn2) recombinant protein for therapy of retinopathy in a retina-specific Fbn2 knock-down mouse model

Year: 2026

Type: erratum

Abstract: As a result of errors during figure assembly, several images in Figure 4 and 5 derived from the same source data. Specifically, the following images are overlapping: panels for fbn2-0.30 µg (2nd fbn2) and fbn2-3.0 µg (AAV-sh-fbn2) in Figure 4A, panels for fbn2-0.30 µg (3rd fbn2) and fbn2-1.50 µg (1st fbn2) in Figure 4A, panels for fbn2-0.75 µg (AAV-sh-fbn2) and fbn2-3.0 µg (2nd fbn2) in Figure 4A, panels for NC (AAV-sh-fbn2) and AAV-NC (AAV-sh-fbn2) in Figure 5, panels for AAV-NC (baseline) and AAV-NC (3rd fbn2) in Figure 5, and panels for fbn2-0.75 µg (baseline) and fbn2-0.75 µg (3rd fbn2) in Figure 5.

Source: Scientific Reports

DOI: 10.1038/s41598-026-67579-7